21.67
price up icon0.00%   +0.00
after-market  After Hours:  21.67 
loading
Evolent Health Inc stock is currently priced at $21.67, with a 24-hour trading volume of 830.17K. It has seen a +0.00% increased in the last 24 hours and a -6.07% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $21.81 pivot point. If it approaches the $21.42 support level, significant changes may occur.
Previous Close:
$21.67
Open:
$21.48
24h Volume:
830.17K
Market Cap:
$2.49B
Revenue:
$1.96B
Net Income/Loss:
$-113.04M
P/E Ratio:
-21.25
EPS:
-1.02
Net Cash Flow:
$113.84M
1W Performance:
-8.64%
1M Performance:
-6.07%
6M Performance:
-28.58%
1Y Performance:
-24.23%
1D Range:
Value
$21.38
$21.80
52W Range:
Value
$20.54
$35.00

Evolent Health Inc Stock (EVH) Company Profile

Name
Name
Evolent Health Inc
Name
Phone
571-389-6000
Name
Address
800 North Glebe Road, Suite 500, Arlington
Name
Employee
2,600
Name
Twitter
@EvolentHealth
Name
Next Earnings Date
2024-06-06
Name
Latest SEC Filings
Name
EVH's Discussions on Twitter

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-03-24 Initiated Barclays Overweight
Dec-06-23 Initiated JMP Securities Mkt Outperform
Oct-16-23 Initiated UBS Buy
Apr-12-23 Initiated Stephens Overweight
Nov-01-22 Initiated Truist Hold
Jul-29-22 Initiated RBC Capital Mkts Outperform
Mar-30-22 Initiated Guggenheim Buy
Nov-18-21 Upgrade JP Morgan Neutral → Overweight
Apr-29-21 Resumed JP Morgan Neutral
Jan-07-21 Initiated BTIG Research Buy
Jul-06-20 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jun-05-20 Downgrade Goldman Buy → Neutral
Jun-02-20 Downgrade Cantor Fitzgerald Overweight → Neutral
Oct-05-18 Resumed Leerink Partners Outperform
Jun-04-18 Initiated Piper Jaffray Overweight
Apr-24-18 Resumed JP Morgan Neutral
Sep-20-17 Initiated KeyBanc Capital Mkts Overweight
Jun-02-17 Initiated Robert W. Baird Outperform
Mar-14-17 Initiated Oppenheimer Outperform
Jan-13-17 Upgrade Wells Fargo Market Perform → Outperform
Oct-28-16 Resumed JP Morgan Overweight
Aug-05-16 Reiterated FBR Capital Outperform
Jul-26-16 Initiated Jefferies Buy
Jul-13-16 Reiterated FBR Capital Outperform
Mar-29-16 Initiated FBR Capital Outperform
Jan-06-16 Initiated Canaccord Genuity Buy
Jun-30-15 Initiated Goldman Buy
Jun-30-15 Initiated JP Morgan Overweight
Jun-30-15 Initiated Leerink Partners Outperform
Jun-30-15 Initiated Sun Trust Rbsn Humphrey Buy
View All

Evolent Health Inc Stock (EVH) Financials Data

Evolent Health Inc (EVH) Revenue 2024

EVH reported a revenue (TTM) of $1.96 billion for the quarter ending December 31, 2023, a +45.26% rise year-over-year.
loading

Evolent Health Inc (EVH) Net Income 2024

EVH net income (TTM) was -$113.04 million for the quarter ending December 31, 2023, a -489.86% decrease year-over-year.
loading

Evolent Health Inc (EVH) Cash Flow 2024

EVH recorded a free cash flow (TTM) of $113.84 million for the quarter ending December 31, 2023, a +328.07% increase year-over-year.
loading

Evolent Health Inc (EVH) Earnings per Share 2024

EVH earnings per share (TTM) was -$1.27 for the quarter ending December 31, 2023, a -535.00% decline year-over-year.
loading
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
$26.71
price down icon 1.00%
$8.39
price down icon 1.41%
health_information_services WAY
$21.62
price down icon 1.73%
$28.08
price down icon 5.96%
health_information_services RCM
$12.48
price down icon 0.48%
Cap:     |  Volume (24h):